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Graphical Abstract 
 
 
 
Highlights 
 
 The toxicological findings in driver and motorcycle fatalities in Scotland have been 
examined. 
 Fifty-seven percent of the cases examined were positive for drugs and/or alcohol. 
 The most common findings were alcohol and cannabinoids. 
 
Abstract 
 
Fatal motor vehicle crashes (MVCs) continue to be a common occurrence worldwide. This paper 
presents a retrospective analysis of the toxicological investigation of drivers and motorcyclists fatally 
injured in MVCs in Scotland from 2012 to 2015. One hundred and eighteen cases with full 
toxicological analysis, i.e., alcohol, drugs of abuse and prescription drugs, were examined. Of those 
118 MVC cases, 74 (63%) were car drivers, 32 (27%) were motorcyclists and the remaining were 
drivers of other vehicles such as large goods vehicles. The majority of deceased drivers and 
motorcyclists were male (N = 104, 88%). For the toxicological findings, 51 (43%) were negative, and 
of the 67 (57%) positive cases, alcohol and cannabinoids were the most frequently detected 
substances, followed by opiates and benzodiazepines. Fifteen percent of all drivers and motorcyclists 
were over the prescribed blood alcohol limit at the time of analysis. In comparison to previous reports 
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of drug use by drivers in Scotland, benzodiazepines and NPS were less common findings in fatally 
injured drivers and motorcyclists than in drivers suspected of being impaired. 
 
Introduction  
 
It has long been recognized that alcohol and certain drugs may impair a person’s driving ability [1]. It 
is also well known that drug use by drivers can increase the risk of being killed in motor vehicle 
collisions (MVCs) [2-4]. Both illicit psychoactive drugs such as cannabis and amphetamine, and 
prescription medications such as benzodiazepines can impair driving [5].  
 
Fatal MVCs continue to be a common occurrence worldwide, with the World Health Organisation 
reporting that 1.25 million road traffic deaths occurred globally in 2013 [6]. Surveys of the incidence 
of drugs and alcohol in MVCs have been carried out in numerous countries, including Australia [7], 
Brazil [8], Canada [1], England & Wales [9, 10], France [11], Jordan [12], New Zealand [13], 
Norway [14, 15], Spain [16], Sweden [17] and other Northern European Countries [18], and the USA 
[19]. However, little is known about how frequently drugs are involved in fatal MVCs in Scotland, 
with the last detailed study having been published in 1999, and then only for the Strathclyde region 
[20]. Updated information is required in order to reflect changes in the availability of new substances, 
and changes in drug use trends and legislation [9]. 
 
The Toxicology Laboratory based within Forensic Medicine & Science at the University of Glasgow 
receives post-mortem cases from all regions of Scotland with the exception of the far northern 
regions. All post-mortem cases submitted to the laboratory for toxicological investigations are 
recorded within the in-house database, which also incorporates some demographic information [21]. 
 
The aim of this study was to examine the toxicological findings in recently fatally injured drivers and 
motorcyclists in Scotland, and analyse them with respect to gender, age, vehicle type and drug and 
alcohol findings. 
 
Method  
 
Fatal MVC cases received by the laboratory between June 2012 and September 2015 involving 
deceased drivers and motorcyclists were selected for this study. Deceased cyclists, pedestrians and 
passengers were not included in the scope. One hundred and forty-six cases were identified from the 
cause of death entered in the in-house database (for West of Scotland cases) or from case 
documentation (for other areas of Scotland). 
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As part of routine casework for these fatalities when they were initially submitted, whole peripheral 
post-mortem blood samples were collected. Preserved blood samples were analysed for alcohol (GC-
FID) and unpreserved blood samples were analysed for drugs of abuse (ELISA), paracetamol (HPLC) 
and basic drugs (GC-MS) as a minimum. The basic drugs analysis targets a range of prescription 
medications including antidepressants, antipsychotics, antihistamines and analgesics such as 
methadone. The core drug groups recommended in the guidelines for this type of study were all tested 
[22]. 
 
Presumptive ELISA positives were confirmed by more specific and sensitive mass spectrometric 
techniques (GC-MS and LC-MS/MS) on unpreserved blood samples, except for cocaine analyses, 
which were carried out on preserved blood. Urine and vitreous humour samples were available in 
some cases and were analysed for alcohol and, if applicable, opiates. However, findings in urine and 
vitreous humour are not reported in this study. Hospital samples were analysed in nine cases (N = 3 
whole blood samples and N = 6 serum samples). In cases where emergency medical treatment was 
indicated in the case records, findings of morphine, ketamine, midazolam or lidocaine were excluded.  
 
Results & Discussion  
 
Of the 146 cases identified, only 118 had full toxicological results. In December 2014 the Scottish 
Government reduced the legal blood alcohol concentration (BAC) limit for drivers from 80 mg/100 
mL to 50 mg/100 mL. Forty-nine of the cases examined in this study occurred after the new limit was 
introduced and 97 occurred before. A summary of the results of this study is shown in Table 1. 
 
 
Case type (N = 118) N % 
Negative 51 43 
Alcohol-only positive (BAC ≥10 mg/100 mL) 9 8 
Drug-only positive 43 36 
Alcohol and drug positive 15 13 
Car drivers 74 63 
Motorcyclists 32 27 
Other (LGV, minibus, van, tractor, scooter, quad bike) 12 10 
Table 1. Summary of the cases examined. 
 
Of the 118 cases examined, 88% of the drivers and motorcyclists were male, with only 12% of 
deceased drivers being female. All of the females in this study were car drivers. The mean age of 
female drivers (N = 14) was 44, range = 18–71, and the mean age of male drivers and motorcyclists 
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(N = 104) was 41, range = 17–86. The mean age for both genders was 41.5. The gender distribution 
for this study is shown in Figure 1.  
 
Figure 1. Age breakdown of fatal MVCs by gender.  
 
In this study, 24 (20% of all fatalities) drivers or motorcyclists were positive for alcohol, with or 
without drugs. The BACs were characterised by a mean and median of 125 mg/100 mL with a range 
of 10–256 mg/100 mL. Of the 24 alcohol-positive drivers and motorcyclists, all but one were male, in 
agreement with previous research indicating that men in Scotland are more likely to drive after 
drinking than women [23].  
 
It should be noted that five of the BACs reported in this study were <50 mg/100 mL (concentrations 
of 10, 10, 12, 24 and 38 mg/100 mL, all post-mortem samples) and that the interpretation of BACs in 
post-mortem cases can be complicated by post-mortem alcohol production. Upon decomposition, 
alcohol can be produced by the action of microbes and the fermentation of glucose [12]. This 
phenomenon can lead to BACs of up to 60 mg/100 mL [24]. Consequently, the presence of alcohol in 
the five cases mentioned above, could have been due to post-mortem production rather than any ante-
mortem consumption of alcohol by the drivers. 
 
Fifteen percent of all fatalities in this study (N = 18) involved a driver or motorcyclist who was over 
the prescribed blood alcohol limit at the time of analysis. This is lower than all of the similar studies 
reported in the literature, including the 21% in Sweden (limit = 20 mg/100 mL) [17], 11% in France 
(limit = 50 mg/100 mL) [11], 25% in Norway (limit = 20 mg/100 mL) [14], 36% in Brazil (zero 
tolerance) [8], and 29% in Australia (limit = 50 mg/100 mL) [7]. Of the alcohol-positive drivers, 75% 
were over the prescribed limit at the time of analysis in this study, compared to 67% in a study in 
England & Wales (limit = 80 mg/100 mL) [9]. 
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Across the three-year period examined, data showed the use of drugs alone increased, while the use of 
a combination of drugs and alcohol decreased. Only 4 cases were examined from 2012, so these cases 
are excluded for this comparison only to leave 114 cases with full toxicological data. The number of 
cases involving drug use alone in fatal driver MVCs from January–December 2013 was found to be 
11 (38% of the year’s cases), 10 in 2014 (25%) and 21 in 2015 (47%); it must be noted that the data 
for 2015 is incomplete. Alcohol and drug use were found in 14% (N = 4) of fatal driver MVCs in 
2013, 10% in 2014 (N = 4) and 13.3% in 2015 (N = 6).  
 
To simplify the statistical analysis, drugs were categorized into drug families [10]. Benzodiazepines 
includes diazepam and its active metabolites desmethyldiazepam, temazepam and oxazepam, and the 
new-generation benzodiazepine phenazepam. The cannabinoid group contains only the active 
ingredient, ∆9-tetrahydrocannabinol (THC), and/or its carboxy metabolite (carboxy-THC); synthetic 
cannabinoid compounds were not included in this study. Opioids includes codeine, morphine, 
dihydrocodeine, tramadol and methadone. These opioids were part of the ‘opiates’ or ‘basic drugs’ 
analyses. Other opioids, such as oxycodone, require specific targeted analyses, carried out on a case-
by-case basis, and were not seen in this study. The drugs included in the other prescription 
medications group were antidepressants, antihistamines and anticonvulsants. The only non-
prescription medications encountered were diphenhydramine and paracetamol, and these are 
categorized as over-the-counter medications. The final drug category was stimulants and 
encompassed cocaine and/or its metabolites benzoylecgonine, ecgonine methyl ester and 
cocaethylene, and the amphetamine-type stimulants amphetamine, ephedrine and 3,4-
methylenedioxymethamphetamine (MDMA, Ecstasy) with its main metabolite, 3,4-
methylenedioxyamphetamine (MDA). 
The most common drug finding in this study was cannabinoids (N = 24, 20% of all fatalities), with 
THC itself present in 8 of the 24 cases and always accompanied by carboxy-THC. Evidence of 
cannabis use was present in 10 cases in 2013 (34.5% of the year’s cases), 7 cases in 2014 (17.5%) and 
7 cases in 2015 (15.2%). 
 
In studies concerning fatally injured drivers and motorcyclists from various countries, the incidence of 
drugs is variable, as is the range of drugs encountered. However, as in this case, cannabis use is often 
the most commonly detected, after alcohol. Comparison of cannabis prevalence with other studies in 
the literature is fraught with difficulties, with some analysing for THC only, others looking for a range 
of metabolites or other cannabinoids, and some papers not reporting their target analyte(s). 
 
The percentage of cannabis positive cases in this study is higher than the 3% reported in Sweden (as 
THC) [17], 7% reported in France (as THC) [11] and 9.8% reported in the USA (analyte not stated) 
[25]. But lower than the 27% reported in Canada (as THC and/or carboxy-THC) [1] and 30% reported 
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in New Zealand (as THC) [13]. The high prevalence of cannabis use in these studies likely reflects the 
fact that cannabis is the most prevalent drug used across the UK and worldwide [10], although it was 
not detected at all in a study from Jordan [12], or in the earlier study of MVC fatalities in Scotland 
[20]. Cannabis (as carboxy-THC) was also the most common drug finding in deceased motorcyclists 
in a study in England & Wales [9]. 
 
It should be noted that cannabis metabolites persist for some time in the body before they are 
eliminated, and can therefore be detected long after any psychological effect or impairment has 
disappeared [26]. In addition, financial and time constraints imposed on some studies may mean that 
cannabis testing is prioritized, leading to an apparent increase in prevalence [24]. 
 
Following cannabinoids, the second most common drug finding was opioids (N = 16, 14% of all 
fatalities). Codeine accounted for the majority of findings (N = 9) followed by tramadol, methadone 
and morphine. Heroin use was confirmed in only one driver (car), verified by the presence of 6-
monoacetylmorphine (6-AM) in the urine sample. However, some of the other morphine-positive 
cases might also have involved heroin use, but a longer survival time meant that the 6-AM metabolite 
was no longer measurable in blood or urine owing to its short elimination half-life [8]. 
 
The third most common drug finding was benzodiazepines (N = 14, 12% of all fatalities). Diazepam 
was found in 13 of the 14 cases, always with one or more active metabolite(s) and once with 
phenazepam. The final case was positive for phenazepam only [23]. Prescription details for each case 
were not always available, and there is an issue with abuse of illicit diazepam in Scotland [27], 
therefore it is not possible to determine if these findings represent legitimate therapeutic use, or illicit 
abuse of diazepam. 
 
The use of diazepam generally increased over the period studied, with 4 cases identified in 2013, 2 
cases in 2014, and 6 cases identified in 2015. Two phenazepam cases were identified in 2013 however 
its use was not seen again in MVCs included in this study. No other new-generation benzodiazepines 
were detected in this study. 
 
Other prescription medications were the fourth most common finding in this study (N = 12, 10% of all 
fatalities) and included the antidepressants amitriptyline, mirtazapine and citalopram, the 
antihistamines chlorpheniramine and cyclizine, and the anticonvulsants gabapentin and valproic acid. 
 
This was followed by over-the-counter medications (N = 10, 8% of all fatalities), with paracetamol 
accounting for 9 of the 10 cases. Paracetamol was found to show the greatest increase in use across 
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the three years, with only 1 case identified in 2013 (3.5% of the year’s cases), 2 cases in 2014 (5% of 
the year’s cases) and 6 cases identified in 2015 (13% of the year’s cases). 
 
Finally, stimulants were found in 10 of the cases examined (8% of all fatalities). Cocaine and/or its 
metabolites was detected in four cases (3% of all fatalities), with cocaine and cocaethylene detected 
only once, in the same case, accompanied by a BAC of 177 mg/100 mL. Amphetamine-type 
stimulants were detected in six cases (5% of all fatalities), with amphetamine itself accounting for half 
of the positives. Methamphetamine was not detected in this study. 
 
In March 2015, new drug driving limits were introduced in England & Wales [28], which do not 
apply in Scotland. Table 2 shows the limits and a breakdown of the results of this study for 
comparison purposes. Note that the limits only apply to selected drugs encountered in this study. 
 
 
Drug or metabolite New 
limit 
(μg/L) 
Number 
positive 
Number above 
the cut-off N (%) 
Benzoylecgonine 50 4 3 (75) 
Cocaine 50 1 1 (100) 
Diazepam§ 500 13 9 (70) 
MDMA 10 2 2 (100) 
Methadone 500 3 2 (67) 
Morphine 80 3 3 (100) 
THC 2 8 8 (100) 
Table 2. A breakdown of the results of this study compared to drug driving legislation in England & Wales. 
 
Finally, the results of this study can be compared to previous reports of drug use by drivers in 
Scotland. In the study by Seymour and Oliver [20], the toxicological findings in 115 fatally injured 
drivers between 1995 and 1997 were examined. In that study, 45% of the cases were negative for both 
drugs and alcohol, compared to 43% in this study. However approximately one-third of all Seymour 
and Oliver’s cases were positive for alcohol (mean BAC = 151 mg/100 mL, range = 10–233 mg/100 
mL for 1997) compared to only one-fifth in this study. There was also a much lower incidence of drug 
use in the earlier study. 
 
                                                     
§ The legislation also includes limits of 300 and 1000 μg/L for oxazepam and temazepam, respectively. The data in this 
study were not compared with these limits, as in each case the profile of results suggested that they were present as 
metabolites of diazepam. 
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In a 10-year review of drug use by living Scottish drivers from 1996–2008, ELISA was used to 
identify the presumptive presence or absence of drugs of abuse [29]. Figure 2 shows a comparison of 
the data from Officer [29] and the corresponding ELISA results from this study. 
 
 
Figure 2. A comparison of the ELISA results for 2008 from Officer [29] with the ELISA results of this study.  
 
It appears from Figure 2 that in living Scottish drivers, benzodiazepine use is more common than in 
deceased drivers and motorcyclists. However, it should be noted that the results in the paper by 
Officer [29] were not confirmed. It also appears from Figure 2 that amphetamine use is more common 
in deceased drivers and motorcyclists than in living drivers, however the number of confirmed 
amphetamine findings in this study was low (N = 6, 5% of all fatalities) indicating that the 26% 
amphetamine-positive ELISA results in this study represent mainly false-positives, a common 
occurrence in post-mortem toxicology. In a roadside survey of 386 oral fluid samples taken from non-
accident-involved drivers in Glasgow during 2003–2004, stimulants (MDMA and cocaine) were the 
most common finding, followed by opiates [30]. 
 
Drivers suspected of being impaired (but not fatally injured) through the use of drugs in Scotland 
have demonstrated a high prevalence of new psychoactive substance (NPS) use, including cathinones, 
piperazines and new-generation benzodiazepines [31]. In this study, testing for NPS was not 
consistently carried out for all cases during the period 2012–2015. 
 
The results of studies of fatal MVCs should be interpreted with caution; there can be a selection bias 
in the number of cases where autopsy and toxicological analysis are carried out [32], and also in the 
extent of toxicological testing. This is evident for MVCs in Scotland, where in a report of 115 MVCs 
during the period 2008 to 2009, 97% of the cases were tested for alcohol, but only 15% were tested 
for drugs [33]. In the present study, 100% of the cases were tested for alcohol and 81% were tested 
for drugs.  
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There are some limitations to this study. Firstly, the specimens tested were all from fatally injured 
drivers and motorcyclists, and hence there is no control group. Therefore, it is not possible to infer 
whether the incidence of drug use was higher among deceased drivers and motorcyclists compared 
with that of the general community [4].  Secondly, it should be noted that the presence of drugs in 
drivers does not necessarily mean that the drug was a causal factor in the MVC [26]. Indeed, some of 
the drugs detected in this study e.g., paracetamol, are not known to produce driving impairment. The 
cause or causes of MVCs are multi-factorial, involving problems with the vehicle, speeding, 
passengers or other distractions, weather conditions and other traffic [5]. Information on whether the 
driver or motorcyclist was deemed responsible for the MVC following crash investigation, was not 
available in this study. 
 
Conclusion  
 
This study has reported the toxicological findings in fatally injured drivers and motorcyclists in 
Scotland from June 2012 to September 2015. Alcohol and cannabis were the most frequently 
encountered drugs, each with a prevalence of 20% of all fatalities, with 15% of all drivers and 
motorcyclists being over the prescribed blood alcohol limit at the time of analysis. The next most 
prevalent drug groups were opioids, benzodiazepines, other prescription and non-prescription 
medications, followed by stimulants. In comparison to previous reports of drug use by drivers in 
Scotland, benzodiazepines and NPS were less common findings in fatally injured drivers and 
motorcyclists than in drivers suspected of being impaired. 
 
Future work will extend this study to fatally injured passengers, pedestrians and cyclists, and also 
focus on any differences in toxicological findings before and after the change in prescribed blood 
alcohol limit in Scotland. 
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